Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1986-08-28
1988-08-02
Gerstl, Robert
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
544366, 544400, A61K 31495, C07D40306, C07D29510
Patent
active
047614153
ABSTRACT:
Potent dopamine-.beta.-hydroxylase inhibitors having the Formula ##STR1## that are useful to inhibit dopamine-.beta.-hydroxylase activity, pharmaceutical compositions including these inhibitors, and methods of using these inhibitors to inhibit dopamine-.beta.-hydroxylase activity in mammals. Also disclosed are novel intermediates useful in preparing the presently invented inhibitors.
REFERENCES:
patent: 3505334 (1970-04-01), Regnier et al.
patent: 4120864 (1978-10-01), Seidel et al.
patent: 4338453 (1982-07-01), Gall
patent: 4532331 (1985-07-01), Frazee et al.
Chemical Abstract 76:135847w.
Chemical Abstract 88:170043.
Chemical Abstract 67:38283.
Chemical Abstract 94:65563.
Chemical Abstract 84:44070.
Chemical Abstract 73:36594.
Chemical Abstract 89:215405.
Chemical Abstract 74:99310.
Chemical Abstract 74:111161.
Chemical Abstract 75:146214.
Chemical Abstract 76:85027.
Chemical Abstract 79:104394.
Chemical Abstract 70:37729.
Chemical Abstract 74:141644.
Chemical Abstract 75:98505.
Chemical Abstract 79:66362.
Chemical Abstract 80:54530.
Chemical Abstract 87:15379.
Chemical Abstract 94:39517.
Chemical Abstract 97:79871.
Modi, K. F. et al., J. Indian Chem. Soc., vol. LIV, pp. 741-742 (Jul. 1977).
Lin, Y. et al., J. Heterocyclic Chem., 17, 1077 (1980).
Khadse et al, CA 85-192667k, New Piperazine Derivatives as Antibacterial Agents.
Gall, CA 97-182434c, Aminoalkyl-1,2,4-Triazoles.
Finkelstein Joseph A.
Kruse Lawrence I.
Leonard Thomas B.
Fabiano Vincent L.
Gerstl Robert
Lourie Alan D.
Shen Cecilia
SmithKline Beckman Corporation
LandOfFree
Dopamine-.beta.-hydroxylase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Dopamine-.beta.-hydroxylase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dopamine-.beta.-hydroxylase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-711984